Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Van Duin, H. Woolson, D. Mallinson, D. Black.
Genomics in target and drug discovery.
Biochem Soc Trans, 31 (2003), pp. 429-432
[2.]
E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, J. Baldwin, et al.
Initial sequencing and analysis of the human genome.
Nature, 409 (2001), pp. 860-921
[3.]
J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, et al.
The sequence of the human genome.
Science, 291 (2001), pp. 1304-1351
[4.]
J. Herrmann.
New kits on the blot: can we microarray the future of atherosclerosis?.
Cardiovasc Res, 60 (2003), pp. 220-222
[5.]
S. Sukhanov, S.Y. Hua, P. Delafontaine.
Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells.
Biochem Biophys Res Commun, 306 (2003), pp. 443-449
[6.]
C.D. Johnson, Y. Balagurunathan, K.P. Lu, M. Tadesse, M.H. Falahatpisheh, R.J. Carroll, et al.
Genomic profiles and predictive biological networks in oxidant-induced atherogenesis.
Physiol Genomics, 13 (2003), pp. 263-275
[7.]
N. Ohura, K. Yamamoto, S. Ichioka, T. Sokabe, H. Nakatsuka, A. Baba, et al.
Global analysis of shear stress-responsive genes in vascular endothelial cells.
J Atheroscler Thromb, 10 (2003), pp. 304-313
[8.]
F. Virgili, R. Ambra, F. Muratori, F. Natella, J. Majewicz, A.M. Minihane, et al.
Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells.
Antioxid Redox Signal, 5 (2003), pp. 237-247
[9.]
B.C. Faber, S. Heeneman, M.J. Daemen, K.B. Cleutjens.
Genes potentially involved in plaque rupture.
Curr Opin Lipidol, 13 (2002), pp. 545-552
[10.]
M.O. Hiltunen, T.T. Tuomisto, M. Niemi, J.H. Brasen, T.T. Rissanen, P. Toronen, et al.
Changes in gene expression in atherosclerotic plaques analyzed using DNA array.
Atherosclerosis, 165 (2002), pp. 23-32
[11.]
A.M. Randi, E. Biguzzi, F. Falciani, P. Merlini, S. Blakemore, E. Bramucci, et al.
Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis.
J Thromb Haemost, 1 (2003), pp. 829-835
[12.]
D. Shiffman, T. Mikita, J.T. Tai, D.P. Wade, J.G. Porter, J.J. Seilhamer, et al.
Large scale gene expression analysis of cholesterol-loaded macrophages.
J Biol Chem, 275 (2000), pp. 37324-37332
[13.]
T. Andersson, S. Borang, M. Larsson, V. Wirta, A. Wennborg, J. Lundeberg, et al.
Novel candidate genes for atherosclerosis are identified by representational difference analysis-based transcript profiling of cholesterol-loaded macrophages.
Pathobiology, 69 (2001), pp. 304-314
[14.]
R. Ohki, K. Yamamoto, H. Mano, R.T. Lee, U. Ikeda, K. Shimada.
Identification of mechanically induced genes in human monocytic cells by DNA microarrays.
J Hypertens, 20 (2002), pp. 685-691
[15.]
A.C. Li, C.K. Glass.
The macrophage foam cell as a target for therapeutic intervention.
Nat Med, 8 (2002), pp. 1235-1242
[16.]
W. Jessup, L. Kritharides.
Metabolism of oxidized LDL by macrophages.
Curr Opin Lipidol, 11 (2000), pp. 473-481
[17.]
M. Artieda, A. Cenarro, D. Tejedor, A. Gañán, P. Álvarez, C. Junquera, et al.
Perfil de expresión génica de macrófagos humanos en cultivo en respuesta a atorvastatina.
Clin Invest Arterioscler, 16 (2004), pp. 175-184
[18.]
G. Llaverias, V. Noe, S. Penuelas, M. Vázquez-Carrera, R.M. Sánchez, J.C. Laguna, et al.
Atorvastatin reduces cd68, fabp4, and hbp expression in oxLDL-treated human macrophages.
Biochem Biophys Res Commun, 318 (2004), pp. 265-274
[19.]
R. Kothapalli, S.J. Yoder, S. Mane, T.P. Jr. Loughran.
Microarray results: how accurate are they?.
BMC Bioinformatics, 3 (2002), pp. 22-32
[20.]
J. Martínez-Botas Mateo, C. Fernández Hernando, J. Sánchez García, O. Pastor Rojo, D. Gómez-Coronado Cáceres, M.A. Lasunción Ripa.
Estudio de la expresión génica mediante matrices de ADNc en células deficientes de colesterol y paradas en g2/M.
Clin Invest Arterioscl, 16 (2004), pp. 2
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.